Benefits of intrauterine treatment on BHFS infants during the neonatal period
| . | No intrauterine treatment . | Intrauterine treatment . | P* . |
|---|---|---|---|
| GA at birth, median (range), wk | 32 (23-39) | 36 (29-41) | <.001 |
| Frequency of term birth, cases (%) | 3 of 26 (12) | 16 of 40 (40) | .014 |
| Hydropic feature at birth, cases (%) | 12 of 22 (55) | 4 of 24 (17) | .007 |
| Birth weight of ≥10th centile, cases (%) | 17 of 21 (81) | 29 of 32 (91) | NS |
| Apgar scores, median (range) | |||
| At 1 min | 3 (0-6) | 8 (1-9) | .003 |
| At 5 min | 6 (1-8) | 9 (5-10) | .003 |
| Required mechanical and/or assisted ventilation, cases (%) | 17 of 20 (85) | 19 of 35 (54) | .02 |
| Duration of mechanical and/or assisted ventilation required, median (range), d | 19 (4-60) | 3 (1-21) | .005 |
| . | No intrauterine treatment . | Intrauterine treatment . | P* . |
|---|---|---|---|
| GA at birth, median (range), wk | 32 (23-39) | 36 (29-41) | <.001 |
| Frequency of term birth, cases (%) | 3 of 26 (12) | 16 of 40 (40) | .014 |
| Hydropic feature at birth, cases (%) | 12 of 22 (55) | 4 of 24 (17) | .007 |
| Birth weight of ≥10th centile, cases (%) | 17 of 21 (81) | 29 of 32 (91) | NS |
| Apgar scores, median (range) | |||
| At 1 min | 3 (0-6) | 8 (1-9) | .003 |
| At 5 min | 6 (1-8) | 9 (5-10) | .003 |
| Required mechanical and/or assisted ventilation, cases (%) | 17 of 20 (85) | 19 of 35 (54) | .02 |
| Duration of mechanical and/or assisted ventilation required, median (range), d | 19 (4-60) | 3 (1-21) | .005 |
NS, not significant.
*P < .05 is significant.